Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Monivent ABXSAT:MONI 23 EV-to-EBITDA is -2.05 as of Aug. 17, 2026. GuruFocus rates XSAT:MONI with a GF Score™ of 23/100 and a GF Value™ of kr0.04 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 513 Medical Devices & Instruments companies, Monivent AB ranks worse than 194931.58% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Monivent AB's enterprise value is kr16.88 Mil.
Monivent AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was kr-8.24 Mil. Therefore, Monivent AB's EV-to-EBITDA for today is -2.05.
The historical rank and industry rank for Monivent AB's EV-to-EBITDA or its related term are showing as below:
XSAT:MONI'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -10.51 Med: -2.63 Max: -0.14
Current: -2.05
During the past 9 years, the highest EV-to-EBITDA of Monivent AB was -0.14. The lowest was -10.51. And the median was -2.63.
XSAT:MONI's EV-to-EBITDA is ranked worse than 100% of 513
companies
in the Medical Devices & Instruments industry
Industry Median: 14.95
vs XSAT:MONI: -2.05
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Monivent AB's PE Ratio (TTM) for today is calculated as:
Monivent AB's share price for today is kr0.189.
Monivent AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.110.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Monivent AB's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:MONI vs ABT, SYK, MDT: EV-to-EBITDA Comparison
For the Medical Devices subindustry, Monivent AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Monivent AB EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Monivent AB's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Monivent AB's EV-to-EBITDA falls into.
Monivent AB's current Enterprise Value is kr16.88 Mil.
Monivent AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-8.24 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Monivent AB (XSAT:MONI) has a EV-to-EBITDA of -2.05 as of Aug. 17, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Monivent AB. According to the industry distribution chart, Monivent AB ranks #999999 out of 513 companies in the Medical Devices & Instruments industry.
Is Monivent AB's EV-to-EBITDA too high?
Monivent AB's current EV-to-EBITDA is -2.05. Based on the distribution chart, Monivent AB ranks #999999 out of 513 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Monivent AB has a GF Score™ of 23/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Monivent AB's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Monivent AB ranks #999999 out of 513 companies for EV-to-EBITDA. This places Monivent AB in the lower half of its industry. The industry median EV-to-EBITDA is 14.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.95, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Monivent AB. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Monivent AB's current EV-to-EBITDA is -2.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Monivent AB stock overvalued right now?
Based on GuruFocus' analysis, Monivent AB (XSAT:MONI) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.04, compared to a current price of kr0.19 — trading 372.5% above its estimated fair value. The current EV-to-EBITDA is -2.05. Monivent AB's overall GF Score™ is 23/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Monivent AB (XSAT:MONI), the current EV-to-EBITDA is -2.05 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Monivent AB (XSAT:MONI) Overvalued in 2026?
Based on GuruFocus' analysis, Monivent AB stock appears to be overvalued.
The current stock price of kr0.19 is trading 372.5% above its estimated GF Value™ of kr0.04.
GuruFocus considers Monivent AB to be Significantly Overvalued.
Key valuation signals for XSAT:MONI:
EV-to-EBITDA: -2.05
GF Value™: kr0.04 vs. price of kr0.19 (372.5% above fair value)
No single metric tells the full story. See the XSAT:MONI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Monivent AB is a medtech company focused on improving the care given to newborn babies in need of respiratory support at birth. The company has developed a patented solution that provides continuous feedback on the volumes of air given to the newborn during manual ventilation. The airflow is measured directly in the face mask and feedback on the ventilation parameters is displayed numerically and graphically in real-time on the external monitor. The company's product is Monivent Neo100.
23GF Score
Get the complete analysis for XSAT:MONI
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:MONI has been successfully added to your 
